Company profile: Immunetrics
1.1 - Company Overview
Company description
- Provider of biosimulation solutions for drug discovery and development, including Thales, a QSP model-building platform that automates and streamlines modeling, generates virtual patient populations, and refines designs; QSP modeling and consulting services; clinical trial simulations and optimization; non-inferiority/bioequivalence analysis; and trial power analysis to predict efficacy and optimize clinical trial design.
Products and services
- QSP Modeling & Consulting Services: Delivers predictive information to assist drug development processes through various mechanistic modeling approaches and consulting services
- Thales: Architects a QSP-focused model-building platform that automates and streamlines the modeling process, generates virtual patient populations, and iteratively refines model designs
- Clinical Trial Optimization: Engineers simulation-based models that predict outcomes from novel combination therapies, simulate complex scenarios, and optimize timing for interventions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Immunetrics
AiCure
HQ: United States
Website
- Description: Provider of AI-driven data analytics to understand patient response to treatments, offering a regulatory-compliant platform to capture and analyze digital biomarkers for predicting participant behavior and treatment response, a Patient Connect mobile app with computer vision for real-time dosing guidance and adherence, site services supporting clinical operations and engagement, and OpenDBM for open-source access to digital biomarker algorithms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AiCure company profile →
ZebiAI
HQ: United States
Website
- Description: Provider of a platform that applies massive experimental DNA-encoded library datasets and machine learning to accelerate small molecule drug discovery, support target validation, and advance new therapeutics for unmet medical needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ZebiAI company profile →
Horizon Lab Systems
HQ: United States
Website
- Description: Provider of configurable, secure LIMS for clinical and medical labs, integrating with Clinisys. Offers HORIZON LIMS (sample management, data collection, reporting; cloud or on‑premise), LabOnline portal, Logbook ELN, Field offline data capture, instrument integration for automation and data import, and analytical, financial, and operational reporting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Horizon Lab Systems company profile →
Faculty Opinions
HQ: United Kingdom
Website
- Description: Provider of a discovery tool for qualitative assessment of published research, leveraging a faculty of over 8,000 leading life science and medicine experts who comment on and validate key publications. Offers H1 Connect for global health opportunities and training, H1 Profile to build credibility and apply, and a WhatsApp community for global peer collaboration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Faculty Opinions company profile →
NewLimit
HQ: United States
Website
- Description: Provider of epigenetic reprogramming medicines and technologies to extend human healthspan by restoring youthful function in aging cells and targeting age-related diseases. Offerings include single-cell genomics, machine learning models for experimental prioritization, in silico experimental models, epigenetic editing, and functional genomics screens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NewLimit company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Immunetrics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Immunetrics
2.2 - Growth funds investing in similar companies to Immunetrics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Immunetrics
4.2 - Public trading comparable groups for Immunetrics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →